Cargando…

Mining Sudanese Medicinal Plants for Antiprotozoal Agents

Neglected tropical diseases are major health hazards in developing countries. Annually, up to 30 million people are affected by either Chagas disease, African trypansomiasis or leishmaniasis, and more than 200 million by malaria. Most of the currently available drugs have drawbacks in terms of toxic...

Descripción completa

Detalles Bibliográficos
Autores principales: Mahmoud, Abdelhalim Babiker, Mäser, Pascal, Kaiser, Marcel, Hamburger, Matthias, Khalid, Sami
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295952/
https://www.ncbi.nlm.nih.gov/pubmed/32581814
http://dx.doi.org/10.3389/fphar.2020.00865
_version_ 1783546744475222016
author Mahmoud, Abdelhalim Babiker
Mäser, Pascal
Kaiser, Marcel
Hamburger, Matthias
Khalid, Sami
author_facet Mahmoud, Abdelhalim Babiker
Mäser, Pascal
Kaiser, Marcel
Hamburger, Matthias
Khalid, Sami
author_sort Mahmoud, Abdelhalim Babiker
collection PubMed
description Neglected tropical diseases are major health hazards in developing countries. Annually, up to 30 million people are affected by either Chagas disease, African trypansomiasis or leishmaniasis, and more than 200 million by malaria. Most of the currently available drugs have drawbacks in terms of toxicity, limited oral availability, development of resistance, or non-affordability. Tropical plants of the arid zones are a treasure chest for the discovery of bioactive secondary metabolites. This study aims to compile Sudanese medicinal plants, validate their antiprotozoal activities, and identify active molecules. We have performed a survey of medicinal plants of Sudan and selected 62 that are being used in Sudanese traditional medicine. From these, we collected materials such as leaves, stem, bark, or fruit. The plant materials were extracted in 70% ethanol and further fractionated by liquid-liquid partitioning using solvents of increasing polarity. This resulted in a library of 235 fractions. The library was tested in vitro against Plasmodium falciparum (erythrocytic stages), Trypanosoma brucei rhodesiense (bloodstream forms), Trypanosoma cruzi (intracellular amastigotes), and Leishmania donovani (axenic amastigotes). Active fractions were also tested for cytotoxicity. Of the 235 fractions, 125 showed growth inhibitory activity >80% at 10 μg/ml, and >50% at 2 μg/ml against at least one of the protozoan parasites. Plasmodium falciparum was the most sensitive of the parasites, followed by T. b. rhodesiense and L. donovani. Only few hits were identified for T. cruzi, and these were not selective. Contrary to expectation based on phylogeny, but in agreement with previous results, a large number of extracts displayed mutual activity against T. brucei and P. falciparum. HPLC-based activity profiling for selected active extracts was performed to identify the bioactive principles. Active compounds identified by dereplication were guieranone A from Guiera senegalensis J.F.Gmel.; pseudosemiglabrin from Tephrosia apollinea (Delile) DC; ellagic acid and quercetin from Terminalia leiocarpa (DC.) Baill.; and catechin, ethyl gallate, and epicatechin gallate from Vachellia nilotica (L.) P.J.H.Hurter & Mabb. Also the extracts of Croton gratissimus var. gratissimus and Cuscuta hyalina Roth ex Schult. exhibited promising antitrypanosomatid activity. This assessment provides a comprehensive overview of Sudanese medicinal plants and supports the notion that they are a potential source of bioactive molecules against protozoan parasites.
format Online
Article
Text
id pubmed-7295952
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-72959522020-06-23 Mining Sudanese Medicinal Plants for Antiprotozoal Agents Mahmoud, Abdelhalim Babiker Mäser, Pascal Kaiser, Marcel Hamburger, Matthias Khalid, Sami Front Pharmacol Pharmacology Neglected tropical diseases are major health hazards in developing countries. Annually, up to 30 million people are affected by either Chagas disease, African trypansomiasis or leishmaniasis, and more than 200 million by malaria. Most of the currently available drugs have drawbacks in terms of toxicity, limited oral availability, development of resistance, or non-affordability. Tropical plants of the arid zones are a treasure chest for the discovery of bioactive secondary metabolites. This study aims to compile Sudanese medicinal plants, validate their antiprotozoal activities, and identify active molecules. We have performed a survey of medicinal plants of Sudan and selected 62 that are being used in Sudanese traditional medicine. From these, we collected materials such as leaves, stem, bark, or fruit. The plant materials were extracted in 70% ethanol and further fractionated by liquid-liquid partitioning using solvents of increasing polarity. This resulted in a library of 235 fractions. The library was tested in vitro against Plasmodium falciparum (erythrocytic stages), Trypanosoma brucei rhodesiense (bloodstream forms), Trypanosoma cruzi (intracellular amastigotes), and Leishmania donovani (axenic amastigotes). Active fractions were also tested for cytotoxicity. Of the 235 fractions, 125 showed growth inhibitory activity >80% at 10 μg/ml, and >50% at 2 μg/ml against at least one of the protozoan parasites. Plasmodium falciparum was the most sensitive of the parasites, followed by T. b. rhodesiense and L. donovani. Only few hits were identified for T. cruzi, and these were not selective. Contrary to expectation based on phylogeny, but in agreement with previous results, a large number of extracts displayed mutual activity against T. brucei and P. falciparum. HPLC-based activity profiling for selected active extracts was performed to identify the bioactive principles. Active compounds identified by dereplication were guieranone A from Guiera senegalensis J.F.Gmel.; pseudosemiglabrin from Tephrosia apollinea (Delile) DC; ellagic acid and quercetin from Terminalia leiocarpa (DC.) Baill.; and catechin, ethyl gallate, and epicatechin gallate from Vachellia nilotica (L.) P.J.H.Hurter & Mabb. Also the extracts of Croton gratissimus var. gratissimus and Cuscuta hyalina Roth ex Schult. exhibited promising antitrypanosomatid activity. This assessment provides a comprehensive overview of Sudanese medicinal plants and supports the notion that they are a potential source of bioactive molecules against protozoan parasites. Frontiers Media S.A. 2020-06-09 /pmc/articles/PMC7295952/ /pubmed/32581814 http://dx.doi.org/10.3389/fphar.2020.00865 Text en Copyright © 2020 Mahmoud, Mäser, Kaiser, Hamburger and Khalid http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Mahmoud, Abdelhalim Babiker
Mäser, Pascal
Kaiser, Marcel
Hamburger, Matthias
Khalid, Sami
Mining Sudanese Medicinal Plants for Antiprotozoal Agents
title Mining Sudanese Medicinal Plants for Antiprotozoal Agents
title_full Mining Sudanese Medicinal Plants for Antiprotozoal Agents
title_fullStr Mining Sudanese Medicinal Plants for Antiprotozoal Agents
title_full_unstemmed Mining Sudanese Medicinal Plants for Antiprotozoal Agents
title_short Mining Sudanese Medicinal Plants for Antiprotozoal Agents
title_sort mining sudanese medicinal plants for antiprotozoal agents
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7295952/
https://www.ncbi.nlm.nih.gov/pubmed/32581814
http://dx.doi.org/10.3389/fphar.2020.00865
work_keys_str_mv AT mahmoudabdelhalimbabiker miningsudanesemedicinalplantsforantiprotozoalagents
AT maserpascal miningsudanesemedicinalplantsforantiprotozoalagents
AT kaisermarcel miningsudanesemedicinalplantsforantiprotozoalagents
AT hamburgermatthias miningsudanesemedicinalplantsforantiprotozoalagents
AT khalidsami miningsudanesemedicinalplantsforantiprotozoalagents